EU bans 700 generic medicines of GVK Biosciences

Q.  Who has banned the marketing of around 700 generic medicines for alleged manipulation of clinical trials conducted by India's pharmaceutical research company GVK Biosciences?
- Published on 27 Jul 15

a. Indian Medical Association
b. European Union
c. United States
d. United Nation Organisation

ANSWER: European Union
 
The ban will come into effect on August 21. According to Germany's drug regulator, the Federal Institute for Medicines and Medical Products and it will be applicable to all 28 member nations. GVK Bio had vehemently denied the allegations. The company offered to conduct fresh studies of the medicines involved at its own cost.

Related Content

➨ Post your comment / Share knowledge


Enter the code shown above:

(Note: If you cannot read the numbers in the above image, reload the page to generate a new one.)
▲